-
1
-
-
68949195990
-
Disease-oriented approach to botulinum toxin use
-
Jankovic, J. Disease-oriented approach to botulinum toxin use. Toxicon 2009, 54, 614-623.
-
(2009)
Toxicon
, vol.54
, pp. 614-623
-
-
Jankovic, J.1
-
2
-
-
78649461297
-
Licence for Botox in so-called chronic migraine
-
discussion 1826
-
Olesen, J.; Tfelt-Hansen, P. Licence for Botox in so-called chronic migraine. Lancet 2010, 376, 1825-1826; discussion 1826.
-
(2010)
Lancet
, vol.376
, pp. 1825-1826
-
-
Olesen, J.1
Tfelt-Hansen, P.2
-
3
-
-
84870561810
-
-
(accessed on 24 October 2011). Available online
-
FDA approves Botox to treat specific form of urinary incontinence. Available online: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm269509.htm?utm_campai gn=Google2&utm_source=fdaSearch&utm_medium=website&utm_term=BOTOX&utm_conten t=10 (accessed on 24 October 2011).
-
FDA approves Botox to treat specific form of urinary incontinence
-
-
-
4
-
-
0032607626
-
The expanding spectrum of clinical uses for botulinum toxin: Healing of chronic anal fissures
-
Hasler, W.L. The expanding spectrum of clinical uses for botulinum toxin: Healing of chronic anal fissures. Gastroenterology 1999, 116, 221-223.
-
(1999)
Gastroenterology
, vol.116
, pp. 221-223
-
-
Hasler, W.L.1
-
5
-
-
0025098542
-
Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: A double-blind study
-
Dykstra, D.D.; Sidi, A.A. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: A double-blind study. Arch. Phys. Med. Rehabil. 1990, 71, 24-26.
-
(1990)
Arch. Phys. Med. Rehabil.
, vol.71
, pp. 24-26
-
-
Dykstra, D.D.1
Sidi, A.A.2
-
6
-
-
0025000163
-
Treatment of spasticity with botulinum toxin: A double-blind study
-
Snow, B.J.; Tsui, J.K.; Bhatt, M.H.; Varelas, M.; Hashimoto, S.A.; Calne, D.B. Treatment of spasticity with botulinum toxin: a double-blind study. Ann. Neurol. 1990, 28, 512-515.
-
(1990)
Ann. Neurol.
, vol.28
, pp. 512-515
-
-
Snow, B.J.1
Tsui, J.K.2
Bhatt, M.H.3
Varelas, M.4
Hashimoto, S.A.5
Calne, D.B.6
-
7
-
-
0024539104
-
Effect of treatment with botulinum toxin on spasticity
-
Das, T.K.; Park, D.M. Effect of treatment with botulinum toxin on spasticity. Postgrad. Med. J. 1989, 65, 208-210.
-
(1989)
Postgrad. Med. J.
, vol.65
, pp. 208-210
-
-
Das, T.K.1
Park, D.M.2
-
8
-
-
0033998602
-
Treatment of tension-type headache with botulinum toxin type A: A double-blind, placebo-controlled study
-
Rollnik, J.D.; Tanneberger, O.; Schubert, M.; Schneider, U.; Dengler, R. Treatment of tension-type headache with botulinum toxin type A: A double-blind, placebo-controlled study. Headache 2000, 40, 300-305.
-
(2000)
Headache
, vol.40
, pp. 300-305
-
-
Rollnik, J.D.1
Tanneberger, O.2
Schubert, M.3
Schneider, U.4
Dengler, R.5
-
10
-
-
3242755055
-
Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin
-
Erbguth, F.J. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov. Disord. 2004, 19, S2-S6.
-
(2004)
Mov. Disord.
, vol.19
-
-
Erbguth, F.J.1
-
12
-
-
0032145932
-
Botulism in the United States: A clinical and epidemiologic review
-
Shapiro, R.L.; Hatheway, C.; Swerdlow, D.L. Botulism in the United States: A clinical and epidemiologic review. Ann. Intern. Med. 1998, 129, 221-228.
-
(1998)
Ann. Intern. Med.
, vol.129
, pp. 221-228
-
-
Shapiro, R.L.1
Hatheway, C.2
Swerdlow, D.L.3
-
13
-
-
0026805297
-
Clostridium botulinum toxins: A general review of involvement in disease, structure, mode of action and preparation for clinical use
-
Hambleton, P. Clostridium botulinum toxins: A general review of involvement in disease, structure, mode of action and preparation for clinical use. J. Neurol. 1992, 239, 16-20.
-
(1992)
J. Neurol.
, vol.239
, pp. 16-20
-
-
Hambleton, P.1
-
14
-
-
84909714921
-
Botulism
-
In, 3rd ed.; Hoeprich, P.D., Eds. Harper & Row: Philadelphia, PA, USA
-
Morris, J.G., Jr.; Hatheway, C.L. Botulism. In Infectious Diseases, 3rd ed.; Hoeprich, P.D., Eds. Harper & Row: Philadelphia, PA, USA, 1983.
-
(1983)
Infectious Diseases
-
-
Morris Jr., J.G.1
Hatheway, C.L.2
-
15
-
-
0642285003
-
Botulism-Information from the World Health Organization
-
Botulism-Information from the World Health Organization. J. Environ. Health. 2003, 65, 51-52.
-
(2003)
J Environ. Health.
, vol.65
, pp. 51-52
-
-
-
16
-
-
17144377560
-
Botulinum toxin: Mechanisms of action
-
Dressler, D.; Adib Saberi, F. Botulinum toxin: Mechanisms of action. Eur. Neurol. 2005, 53, 3-9.
-
(2005)
Eur. Neurol.
, vol.53
, pp. 3-9
-
-
Dressler, D.1
Adib Saberi, F.2
-
17
-
-
0034018885
-
Neurotoxins affecting neuroexocytosis
-
Schiavo, G.; Matteoli, M.; Montecucco, C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80, 717-766.
-
(2000)
Physiol. Rev.
, vol.80
, pp. 717-766
-
-
Schiavo, G.1
Matteoli, M.2
Montecucco, C.3
-
18
-
-
0029080131
-
Molecular genetics of clostridial neurotoxins
-
Minton, N.P. Molecular genetics of clostridial neurotoxins. Curr. Top Microbiol. Immunol. 1995, 195, 161-194.
-
(1995)
Curr. Top Microbiol. Immunol.
, vol.195
, pp. 161-194
-
-
Minton, N.P.1
-
19
-
-
0033884053
-
Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B
-
Swaminathan, S.; Eswaramoorthy, S. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol. 2000, 7, 693-699.
-
(2000)
Nat. Struct. Biol.
, vol.7
, pp. 693-699
-
-
Swaminathan, S.1
Eswaramoorthy, S.2
-
20
-
-
1442349932
-
Role of metals in the biological activity of Clostridium botulinum neurotoxins
-
Eswaramoorthy, S.; Kumaran, D.; Keller, J.; Swaminathan, S. Role of metals in the biological activity of Clostridium botulinum neurotoxins. Biochemistry 2004, 43, 2209-2216.
-
(2004)
Biochemistry
, vol.43
, pp. 2209-2216
-
-
Eswaramoorthy, S.1
Kumaran, D.2
Keller, J.3
Swaminathan, S.4
-
21
-
-
79960693436
-
Studies of the mechanistic details of the pH-dependent association of botulinum neurotoxin with membranes
-
Mushrush, D.J.; Koteiche, H.A.; Sammons, M.A.; Link, A.J.; McHaourab, H.S.; Lacy, D.B. Studies of the mechanistic details of the pH-dependent association of botulinum neurotoxin with membranes. J. Biol. Chem. 2011, 286, 27011-27018.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 27011-27018
-
-
Mushrush, D.J.1
Koteiche, H.A.2
Sammons, M.A.3
Link, A.J.4
McHaourab, H.S.5
Lacy, D.B.6
-
22
-
-
85172057432
-
®: Summary of product characteristics
-
(accessed on 10 September). Available online
-
®: Summary of product characteristics. Merz Pharmaceuticals 2010. Available online: http://www.medicines.org.uk/emc/document.aspx?documentId=20666 (accessed on 10 September 2011).
-
(2011)
Merz Pharmaceuticals 2010
-
-
-
23
-
-
0031770996
-
TetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR
-
Marvaud, J.C.; Eisel, U.; Binz, T.; Niemann, H.; Popoff, M.R. TetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR. Infect. Immun. 1998, 66, 5698-5702.
-
(1998)
Infect. Immun.
, vol.66
, pp. 5698-5702
-
-
Marvaud, J.C.1
Eisel, U.2
Binz, T.3
Niemann, H.4
Popoff, M.R.5
-
24
-
-
0034872279
-
Clostridium botulinum and its neurotoxins: A metabolic and cellular perspective
-
Johnson, E.A.; Bradshaw, M. Clostridium botulinum and its neurotoxins: A metabolic and cellular perspective. Toxicon 2001, 39, 1703-1722.
-
(2001)
Toxicon
, vol.39
, pp. 1703-1722
-
-
Johnson, E.A.1
Bradshaw, M.2
-
25
-
-
0026548114
-
Properties and use of botulinum toxin and other microbial neurotoxins in medicine
-
Schantz, E.J.; Johnson, E.A. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol. Rev. 1992, 56, 80-99.
-
(1992)
Microbiol. Rev.
, vol.56
, pp. 80-99
-
-
Schantz, E.J.1
Johnson, E.A.2
-
26
-
-
0020286209
-
Clostridium botulinum toxins
-
Sakaguchi, G. Clostridium botulinum toxins. Pharmacol. Ther. 1982, 19, 165-194.
-
(1982)
Pharmacol. Ther.
, vol.19
, pp. 165-194
-
-
Sakaguchi, G.1
-
27
-
-
0031866118
-
Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species
-
Chen, F.; Kuziemko, G.M.; Stevens, R.C. Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species. Infect. Immun. 1998, 66, 2420-2425.
-
(1998)
Infect. Immun.
, vol.66
, pp. 2420-2425
-
-
Chen, F.1
Kuziemko, G.M.2
Stevens, R.C.3
-
28
-
-
68849091140
-
XEOMIN is stable without refrigeration: Complexing proteins are not required for stability of botulinum neurotoxin type A preparations
-
Grein, S.; Mander, G.J.; Taylor, H.V. XEOMIN is stable without refrigeration: Complexing proteins are not required for stability of botulinum neurotoxin type A preparations. Toxicon 2008, 51, 13.
-
(2008)
Toxicon
, vol.51
, pp. 13
-
-
Grein, S.1
Mander, G.J.2
Taylor, H.V.3
-
29
-
-
33846598840
-
Genetic diversity among Botulinum Neurotoxin-producing clostridial strains
-
Hill, K.K.; Smith, T.J.; Helma, C.H.; Ticknor, L.O.; Foley, B.T.; Svensson, R.T.; Brown, J.L.; Johnson, E.A.; Smith, L.A.; Okinaka, R.T.; et al. Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J. Bacteriol. 2007, 189, 818-832.
-
(2007)
J. Bacteriol.
, vol.189
, pp. 818-832
-
-
Hill, K.K.1
Smith, T.J.2
Helma, C.H.3
Ticknor, L.O.4
Foley, B.T.5
Svensson, R.T.6
Brown, J.L.7
Johnson, E.A.8
Smith, L.A.9
Okinaka, R.T.10
-
30
-
-
79953870583
-
Clostridium botulinum group III: A group with dual identity shaped by plasmids, phages and mobile elements
-
Skarin, H.; Hafstrom, T.; Westerberg, J.; Segerman, B. Clostridium botulinum group III: A group with dual identity shaped by plasmids, phages and mobile elements. BMC Genomics 2011, 12, 185.
-
(2011)
BMC Genomics
, vol.12
, pp. 185
-
-
Skarin, H.1
Hafstrom, T.2
Westerberg, J.3
Segerman, B.4
-
31
-
-
0031889897
-
Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins
-
Collins, M.D.; East, A.K. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins. J. Appl. Microbiol. 1998, 84, 5-17.
-
(1998)
J. Appl. Microbiol.
, vol.84
, pp. 5-17
-
-
Collins, M.D.1
East, A.K.2
-
32
-
-
16244423360
-
Clostridium botulinum: A bug with beauty and weapon
-
Shukla, H.D.; Sharma, S.K. Clostridium botulinum: A bug with beauty and weapon. Crit. Rev. Microbiol. 2005, 31, 11-18.
-
(2005)
Crit. Rev. Microbiol.
, vol.31
, pp. 11-18
-
-
Shukla, H.D.1
Sharma, S.K.2
-
33
-
-
0035656171
-
Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material
-
Lindstrom, M.; Keto, R.; Markkula, A.; Nevas, M.; Hielm, S.; Korkeala, H. Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material. Appl. Environ. Microbiol. 2001, 67, 5694-5699.
-
(2001)
Appl. Environ. Microbiol.
, vol.67
, pp. 5694-5699
-
-
Lindstrom, M.1
Keto, R.2
Markkula, A.3
Nevas, M.4
Hielm, S.5
Korkeala, H.6
-
34
-
-
0024506750
-
Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes
-
Montecucco, C.; Schiavo, G.; Dasgupta, B.R. Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes. Biochem. J. 1989, 259, 47-53.
-
(1989)
Biochem. J.
, vol.259
, pp. 47-53
-
-
Montecucco, C.1
Schiavo, G.2
Dasgupta, B.R.3
-
35
-
-
79960085306
-
Purification, modeling, and analysis of botulinum neurotoxin subtype A5 (BoNT/A5) from Clostridium botulinum strain A661222
-
Jacobson, M.J.; Lin, G.; Tepp, W.; Dupuy, J.; Stenmark, P.; Stevens, R.C.; Johnson, E.A. Purification, modeling, and analysis of botulinum neurotoxin subtype A5 (BoNT/A5) from Clostridium botulinum strain A661222. Appl. Environ. Microbiol. 2011, 77, 4217-4222.
-
(2011)
Appl. Environ. Microbiol.
, vol.77
, pp. 4217-4222
-
-
Jacobson, M.J.1
Lin, G.2
Tepp, W.3
Dupuy, J.4
Stenmark, P.5
Stevens, R.C.6
Johnson, E.A.7
-
36
-
-
69949105395
-
Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan
-
Umeda, K.; Seto, Y.; Kohda, T.; Mukamoto, M.; Kozaki, S. Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan. J. Clin. Microbiol. 2009, 47, 2720-2728.
-
(2009)
J. Clin. Microbiol.
, vol.47
, pp. 2720-2728
-
-
Umeda, K.1
Seto, Y.2
Kohda, T.3
Mukamoto, M.4
Kozaki, S.5
-
37
-
-
64849090643
-
Catalytic properties of botulinum neurotoxin subtypes A3 and A4
-
Henkel, J.S.; Jacobson, M.; Tepp, W.; Pier, C.; Johnson, E.A.; Barbieri, J.T. Catalytic properties of botulinum neurotoxin subtypes A3 and A4. Biochemistry 2009, 48, 2522-2528.
-
(2009)
Biochemistry
, vol.48
, pp. 2522-2528
-
-
Henkel, J.S.1
Jacobson, M.2
Tepp, W.3
Pier, C.4
Johnson, E.A.5
Barbieri, J.T.6
-
38
-
-
78650885033
-
Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1
-
Pier, C.L.; Chen, C.; Tepp, W.H.; Lin, G.; Janda, K.D.; Barbieri, J.T.; Pellett, S.; Johnson, E.A. Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett. 2011, 585, 199-206.
-
(2011)
FEBS Lett.
, vol.585
, pp. 199-206
-
-
Pier, C.L.1
Chen, C.2
Tepp, W.H.3
Lin, G.4
Janda, K.D.5
Barbieri, J.T.6
Pellett, S.7
Johnson, E.A.8
-
39
-
-
36749064387
-
Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype
-
Chen, Y.; Korkeala, H.; Aarnikunnas, J.; Lindstrom, M. Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype. J. Bacteriol. 2007, 189, 8643-8650.
-
(2007)
J. Bacteriol.
, vol.189
, pp. 8643-8650
-
-
Chen, Y.1
Korkeala, H.2
Aarnikunnas, J.3
Lindstrom, M.4
-
40
-
-
0031002640
-
Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies
-
Kubota, T.; Watanabe, T.; Yokosawa, N.; Tsuzuki, K.; Indoh, T.; Moriishi, K.; Sanda, K.; Maki, Y.; Inoue, K.; Fujii, N. Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies. Appl. Environ. Microbiol. 1997, 63, 1214-1218.
-
(1997)
Appl. Environ. Microbiol.
, vol.63
, pp. 1214-1218
-
-
Kubota, T.1
Watanabe, T.2
Yokosawa, N.3
Tsuzuki, K.4
Indoh, T.5
Moriishi, K.6
Sanda, K.7
Maki, Y.8
Inoue, K.9
Fujii, N.10
-
41
-
-
0033520494
-
Sequence homology and structural analysis of the clostridial neurotoxins
-
Lacy, D.B.; Stevens, R.C. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 1999, 291, 1091-1104.
-
(1999)
J. Mol. Biol.
, vol.291
, pp. 1091-1104
-
-
Lacy, D.B.1
Stevens, R.C.2
-
42
-
-
23944472235
-
Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization
-
Smith, T.J.; Lou, J.; Geren, I.N.; Forsyth, C.M.; Tsai, R.; Laporte, S.L.; Tepp, W.H.; Bradshaw, M.; Johnson, E.A.; Smith, L.A.; et al. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun. 2005, 73, 5450-5457.
-
(2005)
Infect. Immun.
, vol.73
, pp. 5450-5457
-
-
Smith, T.J.1
Lou, J.2
Geren, I.N.3
Forsyth, C.M.4
Tsai, R.5
Laporte, S.L.6
Tepp, W.H.7
Bradshaw, M.8
Johnson, E.A.9
Smith, L.A.10
-
43
-
-
0028432609
-
Botulinum toxin
-
Sesardic, D.; Das, R.E.; Corbel, M.J. Botulinum toxin. J. R. Soc. Med. 1994, 87, 307.
-
(1994)
J.R. Soc. Med.
, vol.87
, pp. 307
-
-
Sesardic, D.1
Das, R.E.2
Corbel, M.J.3
-
44
-
-
0030245670
-
Therapeutic botulinum type A toxin: Factors affecting potency
-
McLellan, K.; Das, R.E.; Ekong, T.A.; Sesardic, D. Therapeutic botulinum type A toxin: Factors affecting potency. Toxicon 1996, 34, 975-985.
-
(1996)
Toxicon
, vol.34
, pp. 975-985
-
-
McLellan, K.1
Das, R.E.2
Ekong, T.A.3
Sesardic, D.4
-
45
-
-
3242775444
-
Detection of antibodies against botulinum toxins
-
Sesardic, D.; Jones, R.G.; Leung, T.; Alsop, T.; Tierney, R. Detection of antibodies against botulinum toxins. Mov. Disord. 2004, 19, S85-S91.
-
(2004)
Mov. Disord.
, vol.19
-
-
Sesardic, D.1
Jones, R.G.2
Leung, T.3
Alsop, T.4
Tierney, R.5
-
46
-
-
0029952424
-
Refinement and validation of an alternative bioassay for potency testing of therapeutic botulinum type A toxin
-
Sesardic, D.; McLellan, K.; Ekong, T.A.; Das, R.G. Refinement and validation of an alternative bioassay for potency testing of therapeutic botulinum type A toxin. Pharmacol. Toxicol. 1996, 78, 283-288.
-
(1996)
Pharmacol. Toxicol.
, vol.78
, pp. 283-288
-
-
Sesardic, D.1
McLellan, K.2
Ekong, T.A.3
Das, R.G.4
-
47
-
-
85172053236
-
Principles of Autonomic and Pheripheral Nervous System Pharmacology
-
In, 2nd ed.; Wilkins, L.W., Ed.; Lippincott Williams: Philadelphia, PA, USA
-
Golan, D.E. Principles of Autonomic and Pheripheral Nervous System Pharmacology. In Principles of Pharmacology; The Physiopathology of Drugs, 2nd ed.; Wilkins, L.W., Ed.; Lippincott Williams: Philadelphia, PA, USA, 2008; pp. 107-125.
-
(2008)
Principles of Pharmacology; The Physiopathology of Drugs
, pp. 107-125
-
-
Golan, D.E.1
-
48
-
-
33749268212
-
Entering neurons: Botulinum toxins and synaptic vesicle recycling
-
Verderio, C.; Rossetto, O.; Grumelli, C.; Frassoni, C.; Montecucco, C.; Matteoli, M. Entering neurons: Botulinum toxins and synaptic vesicle recycling. EMBO Rep. 2006, 7, 995-999.
-
(2006)
EMBO Rep.
, vol.7
, pp. 995-999
-
-
Verderio, C.1
Rossetto, O.2
Grumelli, C.3
Frassoni, C.4
Montecucco, C.5
Matteoli, M.6
-
49
-
-
58549094719
-
Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons
-
Dong, M.; Liu, H.; Tepp, W.H.; Johnson, E.A.; Janz, R.; Chapman, E.R. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol. Biol. Cell 2008, 19, 5226-5237.
-
(2008)
Mol. Biol. Cell
, vol.19
, pp. 5226-5237
-
-
Dong, M.1
Liu, H.2
Tepp, W.H.3
Johnson, E.A.4
Janz, R.5
Chapman, E.R.6
-
50
-
-
65749116965
-
Neuro-exocytosis: Botulinum toxins as inhibitory probes and versatile therapeutics
-
Dolly, J.O.; Lawrence, G.W.; Meng, J.; Wang, J.; Ovsepian, S.V. Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics. Curr. Opin. Pharmacol. 2009, 9, 326-335.
-
(2009)
Curr. Opin. Pharmacol.
, vol.9
, pp. 326-335
-
-
Dolly, J.O.1
Lawrence, G.W.2
Meng, J.3
Wang, J.4
Ovsepian, S.V.5
-
51
-
-
0027947554
-
Effect of disruption of actin filaments by Clostridium botulinum C2 toxin on insulin secretion in HIT-T15 cells and pancreatic islets
-
Li, G.; Rungger-Brandle, E.; Just, I.; Jonas, J.C.; Aktories, K.; Wollheim, C.B. Effect of disruption of actin filaments by Clostridium botulinum C2 toxin on insulin secretion in HIT-T15 cells and pancreatic islets. Mol. Biol. Cell 1994, 5, 1199-1213.
-
(1994)
Mol. Biol. Cell
, vol.5
, pp. 1199-1213
-
-
Li, G.1
Rungger-Brandle, E.2
Just, I.3
Jonas, J.C.4
Aktories, K.5
Wollheim, C.B.6
-
52
-
-
0029019102
-
Cellular localization of synaptotagmin I, II, and III mRNAs in the central nervous system and pituitary and adrenal glands of the rat
-
Marqueze, B.; Boudier, J.A.; Mizuta, M.; Inagaki, N.; Seino, S.; Seagar, M. Cellular localization of synaptotagmin I, II, and III mRNAs in the central nervous system and pituitary and adrenal glands of the rat. J. Neurosci. 1995, 15, 4906-4917.
-
(1995)
J. Neurosci.
, vol.15
, pp. 4906-4917
-
-
Marqueze, B.1
Boudier, J.A.2
Mizuta, M.3
Inagaki, N.4
Seino, S.5
Seagar, M.6
-
53
-
-
0025879767
-
Synaptotagmin II. A novel differentially distributed form of synaptotagmin
-
Geppert, M.; Archer, B.T., III; Sudhof, T.C. Synaptotagmin II. A novel differentially distributed form of synaptotagmin. J. Biol. Chem. 1991, 266, 13548-13552.
-
(1991)
J. Biol. Chem.
, vol.266
, pp. 13548-13552
-
-
Geppert, M.1
Archer III, B.T.2
Sudhof, T.C.3
-
54
-
-
33646248918
-
SV2 is the protein receptor for botulinum neurotoxin A
-
Dong, M.; Yeh, F.; Tepp, W.H.; Dean, C.; Johnson, E.A.; Janz, R.; Chapman, E.R. SV2 is the protein receptor for botulinum neurotoxin A. Science 2006, 312, 592-596.
-
(2006)
Science
, vol.312
, pp. 592-596
-
-
Dong, M.1
Yeh, F.2
Tepp, W.H.3
Dean, C.4
Johnson, E.A.5
Janz, R.6
Chapman, E.R.7
-
55
-
-
33645212684
-
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves
-
Mahrhold, S.; Rummel, A.; Bigalke, H.; Davletov, B.; Binz, T. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 2006, 580, 2011-2014.
-
(2006)
FEBS Lett.
, vol.580
, pp. 2011-2014
-
-
Mahrhold, S.1
Rummel, A.2
Bigalke, H.3
Davletov, B.4
Binz, T.5
-
56
-
-
0141641129
-
Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells
-
Dong, M.; Richards, D.A.; Goodnough, M.C.; Tepp, W.H.; Johnson, E.A.; Chapman, E.R. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 2003, 162, 1293-1303.
-
(2003)
J. Cell Biol.
, vol.162
, pp. 1293-1303
-
-
Dong, M.1
Richards, D.A.2
Goodnough, M.C.3
Tepp, W.H.4
Johnson, E.A.5
Chapman, E.R.6
-
57
-
-
0030064241
-
The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a
-
Nishiki, T.; Tokuyama, Y.; Kamata, Y.; Nemoto, Y.; Yoshida, A.; Sato, K.; Sekiguchi, M.; Takahashi, M.; Kozaki, S. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett. 1996, 378, 253-257.
-
(1996)
FEBS Lett.
, vol.378
, pp. 253-257
-
-
Nishiki, T.1
Tokuyama, Y.2
Kamata, Y.3
Nemoto, Y.4
Yoshida, A.5
Sato, K.6
Sekiguchi, M.7
Takahashi, M.8
Kozaki, S.9
-
58
-
-
27444433349
-
Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins
-
Tsukamoto, K.; Kohda, T.; Mukamoto, M.; Takeuchi, K.; Ihara, H.; Saito, M.; Kozaki, S. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J. Biol. Chem. 2005, 280, 35164-35171.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 35164-35171
-
-
Tsukamoto, K.1
Kohda, T.2
Mukamoto, M.3
Takeuchi, K.4
Ihara, H.5
Saito, M.6
Kozaki, S.7
-
59
-
-
79953289881
-
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors
-
Peng, L.; Tepp, W.H.; Johnson, E.A.; Dong, M. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog. 2011, 7, e1002008.
-
(2011)
PLoS Pathog.
, vol.7
-
-
Peng, L.1
Tepp, W.H.2
Johnson, E.A.3
Dong, M.4
-
60
-
-
69949182315
-
Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor
-
Rummel, A.; Hafner, K.; Mahrhold, S.; Darashchonak, N.; Holt, M.; Jahn, R.; Beermann, S.; Karnath, T.; Bigalke, H.; Binz, T. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J. Neurochem. 2009, 110, 1942-1954.
-
(2009)
J. Neurochem.
, vol.110
, pp. 1942-1954
-
-
Rummel, A.1
Hafner, K.2
Mahrhold, S.3
Darashchonak, N.4
Holt, M.5
Jahn, R.6
Beermann, S.7
Karnath, T.8
Bigalke, H.9
Binz, T.10
-
61
-
-
67649210455
-
Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F
-
Fu, Z.; Chen, C.; Barbieri, J.T.; Kim, J.J.; Baldwin, M.R. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 2009, 48, 5631-5641.
-
(2009)
Biochemistry
, vol.48
, pp. 5631-5641
-
-
Fu, Z.1
Chen, C.2
Barbieri, J.T.3
Kim, J.J.4
Baldwin, M.R.5
-
62
-
-
3142735021
-
Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G
-
Rummel, A.; Karnath, T.; Henke, T.; Bigalke, H.; Binz, T. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 2004, 279, 30865-30870.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 30865-30870
-
-
Rummel, A.1
Karnath, T.2
Henke, T.3
Bigalke, H.4
Binz, T.5
-
63
-
-
77953881240
-
Structural analysis of botulinum neurotoxin type G receptor binding
-
Schmitt, J.; Karalewitz, A.; Benefield, D.A.; Mushrush, D.J.; Pruitt, R.N.; Spiller, B.W.; Barbieri, J.T.; Lacy, D.B. Structural analysis of botulinum neurotoxin type G receptor binding. Biochemistry 2010, 49, 5200-5205.
-
(2010)
Biochemistry
, vol.49
, pp. 5200-5205
-
-
Schmitt, J.1
Karalewitz, A.2
Benefield, D.A.3
Mushrush, D.J.4
Pruitt, R.N.5
Spiller, B.W.6
Barbieri, J.T.7
Lacy, D.B.8
-
64
-
-
0001499477
-
Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin
-
Hansson, H.A.; Holmgren, J.; Svennerholm, L. Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc. Natl. Acad. Sci. USA 1977, 74, 3782-3786.
-
(1977)
Proc. Natl. Acad. Sci. USA
, vol.74
, pp. 3782-3786
-
-
Hansson, H.A.1
Holmgren, J.2
Svennerholm, L.3
-
65
-
-
0037104801
-
Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function
-
Bullens, R.W.; O'Hanlon, G.M.; Wagner, E.; Molenaar, P.C.; Furukawa, K.; Plomp, J.J.; Willison, H.J. Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J. Neurosci. 2002, 22, 6876-6884.
-
(2002)
J. Neurosci.
, vol.22
, pp. 6876-6884
-
-
Bullens, R.W.1
O'Hanlon, G.M.2
Wagner, E.3
Molenaar, P.C.4
Furukawa, K.5
Plomp, J.J.6
Willison, H.J.7
-
66
-
-
0036079926
-
Identification of RNA species in the RNA-toxin complex and structure of the complex in Clostridium botulinum type E
-
Kitamura, M. Identification of RNA species in the RNA-toxin complex and structure of the complex in Clostridium botulinum type E. Biochem. Biophys. Res. Commun. 2002, 291, 154-157.
-
(2002)
Biochem. Biophys. Res. Commun.
, vol.291
, pp. 154-157
-
-
Kitamura, M.1
-
67
-
-
0037031826
-
Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I
-
Yowler, B.C.; Kensinger, R.D.; Schengrund, C.L. Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I. J. Biol. Chem. 2002, 277, 32815-32819.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 32815-32819
-
-
Yowler, B.C.1
Kensinger, R.D.2
Schengrund, C.L.3
-
68
-
-
0345832207
-
Uptake of botulinum neurotoxin into cultured neurons
-
Keller, J.E.; Cai, F.; Neale, E.A. Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 2004, 43, 526-532.
-
(2004)
Biochemistry
, vol.43
, pp. 526-532
-
-
Keller, J.E.1
Cai, F.2
Neale, E.A.3
-
69
-
-
4644364793
-
Presynaptic receptor arrays for clostridial neurotoxins
-
Montecucco, C.; Rossetto, O.; Schiavo, G. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol. 2004, 12, 442-446.
-
(2004)
Trends Microbiol.
, vol.12
, pp. 442-446
-
-
Montecucco, C.1
Rossetto, O.2
Schiavo, G.3
-
70
-
-
79960844485
-
Structural and mutational analyses of the receptor binding domain of botulinum D/C mosaic neurotoxin: Insight into the ganglioside binding mechanism
-
Nuemket, N.; Tanaka, Y.; Tsukamoto, K.; Tsuji, T.; Nakamura, K.; Kozaki, S.; Yao, M.; Tanaka, I. Structural and mutational analyses of the receptor binding domain of botulinum D/C mosaic neurotoxin: Insight into the ganglioside binding mechanism. Biochem. Biophys. Res. Commun. 2011, 411, 433-439.
-
(2011)
Biochem. Biophys. Res. Commun.
, vol.411
, pp. 433-439
-
-
Nuemket, N.1
Tanaka, Y.2
Tsukamoto, K.3
Tsuji, T.4
Nakamura, K.5
Kozaki, S.6
Yao, M.7
Tanaka, I.8
-
71
-
-
80053201230
-
Unique ganglioside recognition strategies for clostridial neurotoxins
-
Benson, M.A.; Fu, Z.; Kim, J.J.; Baldwin, M.R. Unique ganglioside recognition strategies for clostridial neurotoxins. J. Biol. Chem. 2011, 286, 34015-34022.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 34015-34022
-
-
Benson, M.A.1
Fu, Z.2
Kim, J.J.3
Baldwin, M.R.4
-
72
-
-
33845885528
-
Structural basis of cell surface receptor recognition by botulinum neurotoxin B
-
Chai, Q.; Arndt, J.W.; Dong, M.; Tepp, W.H.; Johnson, E.A.; Chapman, E.R.; Stevens, R.C. Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 2006, 444, 1096-1100.
-
(2006)
Nature
, vol.444
, pp. 1096-1100
-
-
Chai, Q.1
Arndt, J.W.2
Dong, M.3
Tepp, W.H.4
Johnson, E.A.5
Chapman, E.R.6
Stevens, R.C.7
-
73
-
-
33745206529
-
Alternative splicing controls neuronal expression of v-ATPase subunit a1 and sorting to nerve terminals
-
Poea-Guyon, S.; Amar, M.; Fossier, P.; Morel, N. Alternative splicing controls neuronal expression of v-ATPase subunit a1 and sorting to nerve terminals. J. Biol. Chem. 2006, 281, 17164-17172.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 17164-17172
-
-
Poea-Guyon, S.1
Amar, M.2
Fossier, P.3
Morel, N.4
-
75
-
-
50549104079
-
Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization
-
Lafourcade, C.; Sobo, K.; Kieffer-Jaquinod, S.; Garin, J.; van der Goot, F.G. Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization. PLoS One 2008, 3, e2758.
-
(2008)
PLoS One
, vol.3
-
-
Lafourcade, C.1
Sobo, K.2
Kieffer-Jaquinod, S.3
Garin, J.4
van der Goot, F.G.5
-
76
-
-
0025116204
-
Membrane interactions of tetanus and botulinum neurotoxins: A photolabelling study with photoactivatable phospholipids
-
Schiavo, G.; Boquet, P.; Dasgupta, B.R.; Montecucco, C. Membrane interactions of tetanus and botulinum neurotoxins: A photolabelling study with photoactivatable phospholipids. J. Physiol. (Paris) 1990, 84, 180-187.
-
(1990)
J. Physiol. (Paris)
, vol.84
, pp. 180-187
-
-
Schiavo, G.1
Boquet, P.2
Dasgupta, B.R.3
Montecucco, C.4
-
77
-
-
80052994116
-
Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly
-
Sun, S.; Suresh, S.; Liu, H.; Tepp, W.H.; Johnson, E.A.; Edwardson, J.M.; Chapman, E.R. Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly. Cell Host Microbe 2011, 10, 237-247.
-
(2011)
Cell Host Microbe
, vol.10
, pp. 237-247
-
-
Sun, S.1
Suresh, S.2
Liu, H.3
Tepp, W.H.4
Johnson, E.A.5
Edwardson, J.M.6
Chapman, E.R.7
-
78
-
-
77953642001
-
Botulinum neurotoxin: A marvel of protein design
-
Montal, M. Botulinum neurotoxin: A marvel of protein design. Annu. Rev. Biochem. 2010, 79, 591-617.
-
(2010)
Annu. Rev. Biochem.
, vol.79
, pp. 591-617
-
-
Montal, M.1
-
79
-
-
0033869011
-
Crystallization and preliminary X-ray analysis of Clostridium botulinum neurotoxin type B
-
Swaminathan, S.; Eswaramoorthy, S. Crystallization and preliminary X-ray analysis of Clostridium botulinum neurotoxin type B. Acta Crystallogr. D Biol. Crystallogr. 2000, 56, 1024-1026.
-
(2000)
Acta Crystallogr. D Biol. Crystallogr.
, vol.56
, pp. 1024-1026
-
-
Swaminathan, S.1
Eswaramoorthy, S.2
-
80
-
-
34548509453
-
Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E
-
Chen, S.; Barbieri, J.T. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E. J. Biol. Chem. 2007, 282, 25540-25547.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 25540-25547
-
-
Chen, S.1
Barbieri, J.T.2
-
81
-
-
0037428398
-
Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons
-
Foran, P.G.; Mohammed, N.; Lisk, G.O.; Nagwaney, S.; Lawrence, G.W.; Johnson, E.; Smith, L.; Aoki, K.R.; Dolly, J.O. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J. Biol. Chem. 2003, 278, 1363-1371.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 1363-1371
-
-
Foran, P.G.1
Mohammed, N.2
Lisk, G.O.3
Nagwaney, S.4
Lawrence, G.W.5
Johnson, E.6
Smith, L.7
Aoki, K.R.8
Dolly, J.O.9
-
82
-
-
3242797403
-
Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
-
Fernandez-Salas, E.; Ho, H.; Garay, P.; Steward, L.E.; Aoki, K.R. Is the light chain subcellular localization an important factor in botulinum toxin duration of action? Mov. Disord. 2004, 19, S23-S34.
-
(2004)
Mov. Disord.
, vol.19
-
-
Fernandez-Salas, E.1
Ho, H.2
Garay, P.3
Steward, L.E.4
Aoki, K.R.5
-
83
-
-
12144291021
-
Plasma membrane localization signals in the light chain of botulinum neurotoxin
-
Fernandez-Salas, E.; Steward, L.E.; Ho, H.; Garay, P.E.; Sun, S.W.; Gilmore, M.A.; Ordas, J.V.; Wang, J.; Francis, J.; Aoki, K.R. Plasma membrane localization signals in the light chain of botulinum neurotoxin. Proc. Natl. Acad. Sci. USA 2004, 101, 3208-3213.
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 3208-3213
-
-
Fernandez-Salas, E.1
Steward, L.E.2
Ho, H.3
Garay, P.E.4
Sun, S.W.5
Gilmore, M.A.6
Ordas, J.V.7
Wang, J.8
Francis, J.9
Aoki, K.R.10
-
84
-
-
20044380238
-
Methods for detection of Clostridium botulinum toxin in foods
-
Sharma, S.K.; Whiting, R.C. Methods for detection of Clostridium botulinum toxin in foods. J. Food Protect. 2005, 68, 1256-1263.
-
(2005)
J. Food Protect.
, vol.68
, pp. 1256-1263
-
-
Sharma, S.K.1
Whiting, R.C.2
-
86
-
-
84860759738
-
Insights into the different catalytic activities of Clostridium neurotoxins
-
Chen, S.; Karalewitz, A.P.; Barbieri, J.T. Insights into the different catalytic activities of Clostridium neurotoxins. Biochemistry 2012, 51, 3941-3947.
-
(2012)
Biochemistry
, vol.51
, pp. 3941-3947
-
-
Chen, S.1
Karalewitz, A.P.2
Barbieri, J.T.3
-
87
-
-
58549116147
-
Domain organization in Clostridium botulinum neurotoxin type E is unique: Its implication in faster translocation
-
Kumaran, D.; Eswaramoorthy, S.; Furey, W.; Navaza, J.; Sax, M.; Swaminathan, S. Domain organization in Clostridium botulinum neurotoxin type E is unique: Its implication in faster translocation. J. Mol. Biol. 2009, 386, 233-245.
-
(2009)
J. Mol. Biol.
, vol.386
, pp. 233-245
-
-
Kumaran, D.1
Eswaramoorthy, S.2
Furey, W.3
Navaza, J.4
Sax, M.5
Swaminathan, S.6
-
88
-
-
0344761960
-
SV2C is a synaptic vesicle protein with an unusually restricted localization: Anatomy of a synaptic vesicle protein family
-
Janz, R.; Südhof, T.C. SV2C is a synaptic vesicle protein with an unusually restricted localization: Anatomy of a synaptic vesicle protein family. Neuroscience 1999, 94, 1279-1290.
-
(1999)
Neuroscience
, vol.94
, pp. 1279-1290
-
-
Janz, R.1
Südhof, T.C.2
-
89
-
-
17444371599
-
Botulinum toxin: Mechanisms of action
-
Dressler, D.; Saberi, F.A.; Barbosa, E.R. Botulinum toxin: Mechanisms of action. Arq. Neuropsiquiatr. 2005, 63, 180-185.
-
(2005)
Arq. Neuropsiquiatr.
, vol.63
, pp. 180-185
-
-
Dressler, D.1
Saberi, F.A.2
Barbosa, E.R.3
-
90
-
-
67049173232
-
FDA requires black box warnings on labeling for botulinum toxin products
-
Kuehn, B.M. FDA requires black box warnings on labeling for botulinum toxin products. J. Am. Med. Assoc. 2009, 301, 2316.
-
(2009)
J. Am. Med. Assoc.
, vol.301
, pp. 2316
-
-
Kuehn, B.M.1
-
91
-
-
53549097062
-
Clinical comparisons of botulinum neurotoxin formulations
-
Brashear, A. Clinical comparisons of botulinum neurotoxin formulations. Neurologist 2008, 14, 289-298.
-
(2008)
Neurologist
, vol.14
, pp. 289-298
-
-
Brashear, A.1
-
92
-
-
34248372532
-
Botulinum toxin type A in chronic migraine
-
Freitag, F.G. Botulinum toxin type A in chronic migraine. Expert Rev. Neurother. 2007, 7, 463-470.
-
(2007)
Expert Rev. Neurother.
, vol.7
, pp. 463-470
-
-
Freitag, F.G.1
-
93
-
-
0035741356
-
Botulinum toxin type B (Myobloc, NeuroBloc): A new choice in cervical dystonia
-
Lew, M.F. Botulinum toxin type B (Myobloc, NeuroBloc): A new choice in cervical dystonia. Expert Rev. Neurother. 2001, 1, 143-152.
-
(2001)
Expert Rev. Neurother.
, vol.1
, pp. 143-152
-
-
Lew, M.F.1
-
94
-
-
0030046196
-
The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia
-
Holzer, S.E.; Ludlow, C.L. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia. Laryngoscope 1996, 106, 86-92.
-
(1996)
Laryngoscope
, vol.106
, pp. 86-92
-
-
Holzer, S.E.1
Ludlow, C.L.2
-
95
-
-
0024991666
-
Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm
-
Kalra, H.K.; Magoon, E.H. Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm. Ophthalmic. Surg. 1990, 21, 335-338.
-
(1990)
Ophthalmic. Surg.
, vol.21
, pp. 335-338
-
-
Kalra, H.K.1
Magoon, E.H.2
-
96
-
-
0028568358
-
Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm
-
Price, J.; O'Day, J. Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm. Aust. New Zeal. J. Ophthalmol. 1994, 22, 255-260.
-
(1994)
Aust. New Zeal. J. Ophthalmol.
, vol.22
, pp. 255-260
-
-
Price, J.1
O'Day, J.2
-
97
-
-
0028345811
-
Development of resistance to botulinum toxin type A in patients with torticollis
-
Greene, P.; Fahn, S.; Diamond, B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov. Disord. 1994, 9, 213-217.
-
(1994)
Mov. Disord.
, vol.9
, pp. 213-217
-
-
Greene, P.1
Fahn, S.2
Diamond, B.3
-
98
-
-
0037216403
-
Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis
-
Dressler, D.; Benecke, R. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur. Neurol. 2003, 49, 34-38.
-
(2003)
Eur. Neurol.
, vol.49
, pp. 34-38
-
-
Dressler, D.1
Benecke, R.2
-
99
-
-
65749109987
-
Efficacy and side-effects of the botulinum toxin A treatment in patients with focal dystonia (in Russian)
-
Likhachev, S.A.; Rushkevich Iu, N.; Chernukha, T.N.; Veevnik, E.V. Efficacy and side-effects of the botulinum toxin A treatment in patients with focal dystonia (in Russian). Zh Nevrol Psikhiatr Im S S Korsakova 2009, 109, 27-31.
-
(2009)
Zh Nevrol Psikhiatr Im S S Korsakova
, vol.109
, pp. 27-31
-
-
Likhachev, S.A.1
Rushkevich Iu, N.2
Chernukha, T.N.3
Veevnik, E.V.4
-
100
-
-
0026355774
-
Clinical correlates of response to botulinum toxin injections
-
Jankovic, J.; Schwartz, K.S. Clinical correlates of response to botulinum toxin injections. Arch. Neurol. 1991, 48, 1253-1256.
-
(1991)
Arch. Neurol.
, vol.48
, pp. 1253-1256
-
-
Jankovic, J.1
Schwartz, K.S.2
-
101
-
-
1842856251
-
Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response
-
Dolimbek, B.Z.; Jankovic, J.; Atassi, M.Z. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response. Immunol. Invest. 2002, 31, 247-262.
-
(2002)
Immunol. Invest.
, vol.31
, pp. 247-262
-
-
Dolimbek, B.Z.1
Jankovic, J.2
Atassi, M.Z.3
-
102
-
-
0037067680
-
How do short neurotoxins bind to a muscular-type nicotinic acetylcholine receptor?
-
Teixeira-Clerc, F.; Menez, A.; Kessler, P. How do short neurotoxins bind to a muscular-type nicotinic acetylcholine receptor? J. Biol. Chem. 2002, 277, 25741-25747.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 25741-25747
-
-
Teixeira-Clerc, F.1
Menez, A.2
Kessler, P.3
-
103
-
-
24144445115
-
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study
-
Truong, D.; Duane, D.D.; Jankovic, J.; Singer, C.; Seeberger, L.C.; Comella, C.L.; Lew, M.F.; Rodnitzky, R.L.; Danisi, F.O.; Sutton, J.P.; et al. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study. Mov. Disord. 2005, 20, 783-791.
-
(2005)
Mov. Disord.
, vol.20
, pp. 783-791
-
-
Truong, D.1
Duane, D.D.2
Jankovic, J.3
Singer, C.4
Seeberger, L.C.5
Comella, C.L.6
Lew, M.F.7
Rodnitzky, R.L.8
Danisi, F.O.9
Sutton, J.P.10
-
104
-
-
79958808497
-
Complexing proteins in botulinum toxin type A drugs: A help or a hindrance?
-
Frevert, J.; Dressler, D. Complexing proteins in botulinum toxin type A drugs: A help or a hindrance? Biologics 2010, 4, 325-332.
-
(2010)
Biologics
, vol.4
, pp. 325-332
-
-
Frevert, J.1
Dressler, D.2
-
105
-
-
82155172909
-
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule
-
Atassi, M.Z.; Jankovic, J.; Steward, L.E.; Aoki, K.R.; Dolimbek, B.Z. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Immunobiology 2012, 217, 17-27.
-
(2012)
Immunobiology
, vol.217
, pp. 17-27
-
-
Atassi, M.Z.1
Jankovic, J.2
Steward, L.E.3
Aoki, K.R.4
Dolimbek, B.Z.5
-
106
-
-
0036841338
-
Considering the immune response to botulinum toxin
-
Critchfield, J. Considering the immune response to botulinum toxin. Clin. J. Pain. 2002, 18, S133-S141.
-
(2002)
Clin. J. Pain.
, vol.18
-
-
Critchfield, J.1
-
107
-
-
79951907939
-
Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin
-
Garcia-Rodriguez, C.; Geren, I.N.; Lou, J.; Conrad, F.; Forsyth, C.; Wen, W.; Chakraborti, S.; Zao, H.; Manzanarez, G.; Smith, T.J.; et al. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng. Des. Sel. 2011, 24, 321-331.
-
(2011)
Protein Eng. Des. Sel.
, vol.24
, pp. 321-331
-
-
Garcia-Rodriguez, C.1
Geren, I.N.2
Lou, J.3
Conrad, F.4
Forsyth, C.5
Wen, W.6
Chakraborti, S.7
Zao, H.8
Manzanarez, G.9
Smith, T.J.10
-
108
-
-
0031984577
-
Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections
-
Sankhla, C.; Jankovic, J.; Duane, D. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections. Mov. Disord. 1998, 13, 150-154.
-
(1998)
Mov. Disord.
, vol.13
, pp. 150-154
-
-
Sankhla, C.1
Jankovic, J.2
Duane, D.3
-
109
-
-
0037426445
-
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
-
Jankovic, J.; Vuong, K.D.; Ahsan, J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003, 60, 1186-1188.
-
(2003)
Neurology
, vol.60
, pp. 1186-1188
-
-
Jankovic, J.1
Vuong, K.D.2
Ahsan, J.3
-
110
-
-
33645107639
-
Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc
-
Dressler, D.; Hallett, M. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc. Eur. J. Neurol. 2006, 13, 11-15.
-
(2006)
Eur. J. Neurol.
, vol.13
, pp. 11-15
-
-
Dressler, D.1
Hallett, M.2
-
111
-
-
34047201026
-
Comparative antigenicity of three preparations of botulinum neurotoxin type A in the rabbit
-
Blumel, J.; Frever, J.; Schwaier, A. Comparative antigenicity of three preparations of botulinum neurotoxin type A in the rabbit. Neurotox. Res. 2006, 9, 238.
-
(2006)
Neurotox. Res.
, vol.9
, pp. 238
-
-
Blumel, J.1
Frever, J.2
Schwaier, A.3
-
112
-
-
65549158884
-
Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy
-
Kanovsky, P.; Bares, M.; Severa, S.; Richardson, A. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy. Dev. Med. Child Neurol. 2009, 51, 436-445.
-
(2009)
Dev. Med. Child Neurol.
, vol.51
, pp. 436-445
-
-
Kanovsky, P.1
Bares, M.2
Severa, S.3
Richardson, A.4
-
113
-
-
0028924664
-
Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease
-
Flynn, D.D.; Ferrari-DiLeo, G.; Mash, D.C.; Levey, A.I. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J. Neurochem. 1995, 64, 1888-1891.
-
(1995)
J. Neurochem.
, vol.64
, pp. 1888-1891
-
-
Flynn, D.D.1
Ferrari-DiLeo, G.2
Mash, D.C.3
Levey, A.I.4
-
114
-
-
0027177289
-
Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: Morphological evidence for cholinergic modulation of excitatory neurotransmission
-
Mrzljak, L.; Levey, A.I.; Goldman-Rakic, P.S. Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: Morphological evidence for cholinergic modulation of excitatory neurotransmission. Proc. Natl. Acad. Sci. USA 1993, 90, 5194-5198.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 5194-5198
-
-
Mrzljak, L.1
Levey, A.I.2
Goldman-Rakic, P.S.3
-
115
-
-
0025130727
-
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia
-
Weiner, D.M.; Levey, A.I.; Brann, M.R. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. Natl. Acad. Sci. USA 1990, 87, 7050-7054.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 7050-7054
-
-
Weiner, D.M.1
Levey, A.I.2
Brann, M.R.3
-
116
-
-
0025313499
-
Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry
-
Vilaro, M.T.; Palacios, J.M.; Mengod, G. Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci. Lett. 1990, 114, 154-159.
-
(1990)
Neurosci. Lett.
, vol.114
, pp. 154-159
-
-
Vilaro, M.T.1
Palacios, J.M.2
Mengod, G.3
-
117
-
-
84860315449
-
Muscarinic Receptors: Their Roles in Disorders of the Central Nervous System and Potential as Therapeutic Targets
-
Scarr, E. Muscarinic Receptors: Their Roles in Disorders of the Central Nervous System and Potential as Therapeutic Targets. CNS Neurosci. Ther. 2011, 18, 369-379.
-
(2011)
CNS Neurosci. Ther.
, vol.18
, pp. 369-379
-
-
Scarr, E.1
-
118
-
-
71549170798
-
Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan
-
Nakamura, K.; Kohda, T.; Umeda, K.; Yamamoto, H.; Mukamoto, M.; Kozaki, S. Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan. Vet. Microbiol. 2010, 140, 147-154.
-
(2010)
Vet. Microbiol.
, vol.140
, pp. 147-154
-
-
Nakamura, K.1
Kohda, T.2
Umeda, K.3
Yamamoto, H.4
Mukamoto, M.5
Kozaki, S.6
-
119
-
-
63849196530
-
Intrahippocampal infusion of botulinum neurotoxin E (BoNT/E) reduces spontaneous recurrent seizures in a mouse model of mesial temporal lobe epilepsy
-
Antonucci, F.; Bozzi, Y.; Caleo, M. Intrahippocampal infusion of botulinum neurotoxin E (BoNT/E) reduces spontaneous recurrent seizures in a mouse model of mesial temporal lobe epilepsy. Epilepsia 2009, 50, 963-966.
-
(2009)
Epilepsia
, vol.50
, pp. 963-966
-
-
Antonucci, F.1
Bozzi, Y.2
Caleo, M.3
-
120
-
-
20044390724
-
Antiepileptic effects of botulinum neurotoxin E
-
Costantin, L.; Bozzi, Y.; Richichi, C.; Viegi, A.; Antonucci, F.; Funicello, M.; Gobbi, M.; Mennini, T.; Rossetto, O.; Montecucco, C.; et al. Antiepileptic effects of botulinum neurotoxin E. J. Neurosci. 2005, 25, 1943-1951.
-
(2005)
J. Neurosci.
, vol.25
, pp. 1943-1951
-
-
Costantin, L.1
Bozzi, Y.2
Richichi, C.3
Viegi, A.4
Antonucci, F.5
Funicello, M.6
Gobbi, M.7
Mennini, T.8
Rossetto, O.9
Montecucco, C.10
-
121
-
-
34247601508
-
BoNT/E prevents seizure-induced activation of caspase 3 in the rat hippocampus
-
Manno, I.; Antonucci, F.; Caleo, M.; Bozzi, Y. BoNT/E prevents seizure-induced activation of caspase 3 in the rat hippocampus. Neuroreport 2007, 18, 373-376.
-
(2007)
Neuroreport
, vol.18
, pp. 373-376
-
-
Manno, I.1
Antonucci, F.2
Caleo, M.3
Bozzi, Y.4
-
122
-
-
41149084007
-
Botulinum neurotoxin E (BoNT/E) reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy
-
Antonucci, F.; di Garbo, A.; Novelli, E.; Manno, I.; Sartucci, F.; Bozzi, Y.; Caleo, M. Botulinum neurotoxin E (BoNT/E) reduces CA1 neuron loss and granule cell dispersion, with no effects on chronic seizures, in a mouse model of temporal lobe epilepsy. Exp. Neurol. 2008, 210, 388-401.
-
(2008)
Exp. Neurol.
, vol.210
, pp. 388-401
-
-
Antonucci, F.1
di Garbo, A.2
Novelli, E.3
Manno, I.4
Sartucci, F.5
Bozzi, Y.6
Caleo, M.7
-
123
-
-
34249789001
-
Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivo
-
Hou, Y.P.; Zhang, Y.P.; Song, Y.F.; Zhu, C.M.; Wang, Y.C.; Xie, G.L. Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivo. Can. J. Physiol. Pharmacol. 2007, 85, 209-214.
-
(2007)
Can. J. Physiol. Pharmacol.
, vol.85
, pp. 209-214
-
-
Hou, Y.P.1
Zhang, Y.P.2
Song, Y.F.3
Zhu, C.M.4
Wang, Y.C.5
Xie, G.L.6
-
124
-
-
34548567008
-
Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential
-
Meng, J.; Wang, J.; Lawrence, G.; Dolly, J.O. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J. Cell. Sci. 2007, 120, 2864-2874.
-
(2007)
J. Cell. Sci.
, vol.120
, pp. 2864-2874
-
-
Meng, J.1
Wang, J.2
Lawrence, G.3
Dolly, J.O.4
-
125
-
-
44049104774
-
Glutamate uptake and release by astrocytes are enhanced by Clostridium botulinum C3 protein
-
Holtje, M.; Hofmann, F.; Lux, R.; Veh, R.W.; Just, I.; Ahnert-Hilger, G. Glutamate uptake and release by astrocytes are enhanced by Clostridium botulinum C3 protein. J. Biol. Chem. 2008, 283, 9289-9299.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 9289-9299
-
-
Holtje, M.1
Hofmann, F.2
Lux, R.3
Veh, R.W.4
Just, I.5
Ahnert-Hilger, G.6
-
126
-
-
0033601298
-
Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues
-
O'Sullivan, G.A.; Mohammed, N.; Foran, P.G.; Lawrence, G.W.; Oliver Dolly, J. Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues. J. Biol. Chem. 1999, 274, 36897-36904.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 36897-36904
-
-
O'Sullivan, G.A.1
Mohammed, N.2
Foran, P.G.3
Lawrence, G.W.4
Oliver Dolly, J.5
-
127
-
-
58149157911
-
Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
-
Gazerani, P.; Pedersen, N.S.; Staahl, C.; Drewes, A.M.; Arendt-Nielsen, L. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain 2009, 141, 60-69.
-
(2009)
Pain
, vol.141
, pp. 60-69
-
-
Gazerani, P.1
Pedersen, N.S.2
Staahl, C.3
Drewes, A.M.4
Arendt-Nielsen, L.5
-
128
-
-
52949097981
-
Beneficial effects of botulinum toxin type A in trigeminal neuralgia
-
Zuniga, C.; Diaz, S.; Piedimonte, F.; Micheli, F. Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq. Neuropsiquiatr. 2008, 66, 500-503.
-
(2008)
Arq. Neuropsiquiatr.
, vol.66
, pp. 500-503
-
-
Zuniga, C.1
Diaz, S.2
Piedimonte, F.3
Micheli, F.4
-
129
-
-
79952332075
-
Botulinum toxin type-A effect as a preemptive treatment in a model of acute trigeminal pain: A pre-clinical double-blind and placebo-controlled study
-
Piovesan, E.J.; Leite Lda, S.; Teive, H.G.; Kowacs, P.A.; Mulinari, R.A.; Radunz, V.; Utiumi, M.; Campos, H.G.; Werneck, L.C. Botulinum toxin type-A effect as a preemptive treatment in a model of acute trigeminal pain: A pre-clinical double-blind and placebo-controlled study. Arq. Neuropsiquiatr. 2011, 69, 56-63.
-
(2011)
Arq. Neuropsiquiatr.
, vol.69
, pp. 56-63
-
-
Piovesan, E.J.1
Leite Lda, S.2
Teive, H.G.3
Kowacs, P.A.4
Mulinari, R.A.5
Radunz, V.6
Utiumi, M.7
Campos, H.G.8
Werneck, L.C.9
-
130
-
-
79953712929
-
2+-triggered exocytosis in neurons and endocrine cells demonstrated with an engineered neurotoxin
-
2+-triggered exocytosis in neurons and endocrine cells demonstrated with an engineered neurotoxin. Biochemistry 2011, 50, 2711-2713.
-
(2011)
Biochemistry
, vol.50
, pp. 2711-2713
-
-
Wang, D.1
Zhang, Z.2
Dong, M.3
Sun, S.4
Chapman, E.R.5
Jackson, M.B.6
|